The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin

Thrombosis Research

Volumn 133, Issue 5, 2014, Pages 855-862

  Schlesinger, Martin ^a   Roblek, Marko ^b   Ortmann, Katrin ^a   Naggi, Annamaria ^c   Torri, Giangiacomo ^c   Borsig, Lubor ^b   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

Author keywords

Cell adhesion; Heparin; Melanoma cell metastasis; Selectins; VLA 4

Indexed keywords

HEPARIN; L SELECTIN; PADGEM PROTEIN; SHORT HAIRPIN RNA; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; TINZAPARIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMETRY; DOWN REGULATION; EXPERIMENTAL MELANOMA; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MELANOMA METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; THROMBOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; CHEMISTRY; DRUG EFFECTS; HUMAN; MELANOMA, EXPERIMENTAL; METABOLISM; METASTASIS; PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTICOAGULANTS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTEGRIN ALPHA4BETA1; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM METASTASIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84898822355     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.02.020     Document Type: Article

References (54)

1. R.W. Groves, M.H. Allen, E.L. Ross, G. Ahsan, J.N. Barker, and D.M. MacDonald Expression of selectin ligands by cutaneous squamous cell carcinoma Am J Pathol 143 1993 1220 1225
2. N. Kojima, K. Handa, W. Newman, and S. Hakomori Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells Biochem Biophys Res Commun 182 1992 1288 1295
3. J.P. Stone, and D.D. Wagner P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer J Clin Invest 92 1993 804 813
4. L. Borsig, R. Wong, J. Feramisco, D.R. Nadeau, N.M. Varki, and A. Varki Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci U S A 98 2001 3352 3357
5. B. Nieswandt, M. Hafner, B. Echtenacher, and D.N. Männel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1999 1295 1300
6. H. Läubli, J.L. Stevenson, A. Varki, N.M. Varki, and L. Borsig L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest Cancer Res 66 2006 1536 1542
7. L. Borsig, R. Wong, R.O. Hynes, N.M. Varki, and A. Varki Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci U S A 99 2002 2193 2198
8. D.B. Taichman, M.I. Cybulsky, I. Djaffar, B.M. Longenecker, J. Teixidó, and G.E. Rice et al. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1 Cell Regul 2 1991 347 355
9. I. Martìn-Padura, R. Mortarini, D. Lauri, S. Bernasconi, F. Sanchez-Madrid, and G. Parmiani et al. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression Cancer Res 51 1991 2239 2241
10. P. Mattila, M.L. Majuri, and R. Renkonen VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines Int J Cancer 52 1992 918 923
11. M. Klemke, T. Weschenfelder, M.H. Konstandin, and Y. Samstag High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers J Cell Physiol 212 2007 368 374
12. G.E. Rice, and M.P. Bevilacqua An inducible endothelial cell surface glycoprotein mediates melanoma adhesion Science 246 1989 1303 1306
13. A. Garofalo, R.G. Chirivi, C. Foglieni, R. Pigott, R. Mortarini, and I. Martin-Padura et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases Cancer Res 55 1995 414 419
14. A. Higashiyama, H. Watanabe, K. Okumura, and H. Yagita Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis Cancer Immunol Immunother 42 1996 231 236
15. H. Okahara, H. Yagita, K. Miyake, and K. Okumura Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis Cancer Res 54 1994 3233 3236
16. D. Schadendorf, J. Heidel, C. Gawlik, L. Suter, and B.M. Czarnetzki Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels J Natl Cancer Inst 87 1995 366 371
17. T.J. Hieken, S.G. Ronan, M. Farolan, A.L. Shilkaitis, and T.K. Das Gupta Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma Anticancer Res 16 1996 2321 2324
18. T.J. Hieken, S.G. Ronan, M. Farolan, A.L. Shilkaitis, D.K. Kim, and T.K. Das Gupta Beta 1 integrin expression in malignant melanoma predicts occult lymph node metastases Surgery 118 1995 669 673 [discussion 673-675]
19. R. Schmidmaier, and P. Baumann ANTI-ADHESION evolves to a promising therapeutic concept in oncology Curr Med Chem 15 2008 978 990
20. G. Agnelli, G. Gussoni, C. Bianchini, M. Verso, M. Mandalà, and L. Cavanna et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Lancet Oncol 10 2009 943 949
21. M. Altinbas, H.S. Coskun, O. Er, M. Ozkan, B. Eser, and A. Unal et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 2004 1266 1271
22. A.K. Kakkar, M.N. Levine, Z. Kadziola, N.R. Lemoine, V. Low, and H.K. Patel et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 2004 1944 1948
23. A.Y.Y. Lee, F.R. Rickles, J.A. Julian, M. Gent, R.I. Baker, and C. Bowden et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism J Clin Oncol 23 2005 2123 2129
24. C.P.W. Klerk, S.M. Smorenburg, H.-M. Otten, A.W.A. Lensing, M.H. Prins, and F. Piovella et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2005 2130 2135
25. H. Laubli, and L. Borsig Heparins attenuate cancer metastasis: are selectins the link? Cancer Invest 27 2009 474 481
26. T.M.H. Niers, C.P.W. Klerk, M. DiNisio, C.J.F. van Noorden, H.R. Büller, and P.H. Reitsma et al. Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit Rev Oncol Hematol 61 2007 195 207
27. S.A. Mousa, and S. Mohamed Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor Thromb Haemost 92 2004 627 633
28. G.C. Jayson, and J.T. Gallagher Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells Br J Cancer 75 1997 9 16
29. N. Hostettler, A. Naggi, G. Torri, R. Ishai-Michaeli, B. Casu, and I. Vlodavsky et al. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins FASEB J 21 2007 3562 3572
30. D.P. Stölting, U. Jaehde, M. Wiese, and G. Bendas Are low molecular weight heparins able to sensitize chemoresistant tumor cells? Int J Clin Pharmacol Ther 51 2013 70 73
31. G. Chalkiadaki, D. Nikitovic, A. Berdiaki, P. Katonis, N.K. Karamanos, and G.N. Tzanakakis Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration IUBMB Life 63 2011 109 119
32. G. Chalkiadaki, D. Nikitovic, P. Katonis, A. Berdiaki, A. Tsatsakis, and I. Kotsikogianni et al. Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes Cancer Lett 312 2011 235 244
33. M. Schlesinger, P. Schmitz, R. Zeisig, A. Naggi, G. Torri, and B. Casu et al. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives Thromb Res 129 2012 603 610
34. A. Naggi, B. Casu, M. Perez, G. Torri, G. Cassinelli, and S. Penco et al. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting J Biol Chem 280 2005 12103 12113
35. J. Fritzsche, D. Simonis, and G. Bendas Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches Thromb Haemost 100 2008 1166 1175
36. M. Schlesinger, D. Simonis, P. Schmitz, J. Fritzsche, and G. Bendas Binding between heparin and the integrin VLA-4 Thromb Haemost 102 2009 816 822
37. E.S. Day, L. Osborn, and A. Whitty Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2 + activation of integrin alpha4beta1 confers a distinct ligand specificity Cell Commun Adhes 9 2002 205 219
38. Y. Takada, X. Ye, and S. Simon The integrins Genome Biol 8 2007 215
39. D.H. Miller, O.A. Khan, W.A. Sheremata, L.D. Blumhardt, G.P.A. Rice, and M.A. Libonati et al. A controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 348 2003 15 23
40. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, and K.W. Kombrinck et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms Blood 110 2007 133 141
41. A.M. Gil-Bernabé, S. Ferjancic, M. Tlalka, L. Zhao, P.D. Allen, and J.H. Im et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice Blood 119 2012 3164 3175
42. J.L. Stevenson, S.H. Choi, and A. Varki Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity Clin Cancer Res 11 2005 7003 7011
43. G.H. Mahabeleshwar, W. Feng, K. Reddy, E.F. Plow, and T.V. Byzova Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis Circ Res 101 2007 570 580
44. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 2010 9 22
45. P.C. Brooks, R.A. Clark, and D.A. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 1994 569 571
46. T. Engl, B. Relja, D. Marian, C. Blumenberg, I. Müller, and W.-D. Beecken et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins Neoplasia 8 2006 290 301
47. J.J. Grzesiak, K.C. Smith, D.W. Burton, L.J. Deftos, and M. Bouvet Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells Surgery 141 2007 804 814
48. E.H. Danen, A.A. van Kraats, I.M. Cornelissen, D.J. Ruiter, and G.N. van Muijen Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis Biochem Biophys Res Commun 226 1996 75 81
49. W. Bao, and S. Strömblad Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen J Cell Biol 167 2004 745 756
50. D.G. Stupack, X.S. Puente, S. Boutsaboualoy, C.M. Storgard, and D.A. Cheresh Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins J Cell Biol 155 2001 459 470
51. H. Zhao, F.P. Ross, and S.L. Teitelbaum Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal Mol Endocrinol 19 2005 771 780
52. Q. Chen, X.H.-F. Zhang, and J. Massagué Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs Cancer Cell 20 2011 538 549
53. Q. Chen, and J. Massagué Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis Clin Cancer Res 18 2012 5520 5525
54. S. Ferjancic, A.M. Gil-Bernabé, S.A. Hill, P.D. Allen, P. Richardson, and T. Sparey et al. VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice Blood 121 2013 3289 3297